Literature DB >> 30467225

Experiences of Individuals Awaiting Lung Transplantation.

Ulrika Skogeland1, Isabelle de Monestrol1, Tove E Godskesen2,3.   

Abstract

Lung transplantation is an established intervention for patients with advanced and life-threatening respiratory disease. Unfortunately, the shortage of organ donors results in a need for organs that greatly exceeds availability. This narrative review aimed to investigate the experiences of patients with respiratory diseases who wait for lung transplantation. Articles were retrieved from medical literature databases. Thirteen qualitative studies were reviewed, one of them used a mixed method. We found that individuals faced varied and complex situations differently while waiting for lung transplantations, depending on physical, psychological, social, and existential factors. Waiting gives hope for a future without the limitations imposed by the disease but also causes great stress. Many individuals struggled with the existential guilt associated with the privilege of having access to transplantation. This review highlighted that support from health-care professionals, next of kin, patients who had previously received a transplantation, and close friends have a vital role to play for individuals waiting for a lung transplantation.
Copyright © 2018 by Daedalus Enterprises.

Entities:  

Keywords:  experiences; lung transplantation; palliative care; respiratory diseases; waiting list

Mesh:

Year:  2018        PMID: 30467225     DOI: 10.4187/respcare.06401

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  3 in total

1.  Evaluating resilience as a predictor of outcomes in lung transplant candidates.

Authors:  Yvonne Tran Bui; Matthew A Hathcock; Roberto P Benzo; Marie M Budev; Satish Chandrashekaran; David B Erasmus; Erika D Lease; Deborah J Levine; Karin L Thompson; Bradley K Johnson; Sheila G Jowsey-Gregoire; Cassie C Kennedy
Journal:  Clin Transplant       Date:  2020-09-23       Impact factor: 2.863

2.  The 3-T Model of Informed Consent for Nonstandard Risk Donors: A Proposal for Transplant Clinical Practice.

Authors:  Alessandra Agnese Grossi; Federico Nicoli; Tullia Maria De Feo; Massimo Cardillo; Gabriella Biffa; Renzo Pegoraro; Carlo Petrini; Rosanna Torelli; Francesca Puoti; Giuseppe Rossini; Giuseppe Piccolo; Sergio Vesconi; Enrico Minetti; Barbara Pozzo; Giuseppe Vanacore; David Paredes; Paolo Antonio Grossi; Mario Picozzi
Journal:  Transplant Direct       Date:  2021-10-22

3.  Soluble factors of mesenchimal stem cells (FS-MSC) as a potential tool to reduce inflammation in donor's lungs after hypovolemic shock.

Authors:  Vinicius Luderer Dias; Karina Andrighetti de Oliveira Braga; Natalia Aparecida Nepomuceno; Liliane Moreira Ruiz; Juan David Ruiz Perez; Aristides Tadeu Correia; Luiz Carlos de Caires Junior; Ernesto Goulart; Mayana Zatz; Paulo Manuel Pêgo-Fernandes
Journal:  J Bras Pneumol       Date:  2021-08-09       Impact factor: 2.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.